Evidence map›Paper›PMID 26742069›Full record

ArticleNutrients2016

Peroxisome Proliferator-Activated Receptor Activation is Associated with Altered Plasma One-Carbon Metabolites and B-Vitamin Status in Rats.

Vegard Lysne, Elin Strand, Gard F T Svingen, Bodil Bjørndal, Eva R Pedersen, Øivind Midttun, Thomas Olsen, Per M Ueland, Rolf K Berge, Ottar Nygård

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Pretreatment withFrontiers in pharmacology · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Transcellular transport of cobalamin in aortic endothelial cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Vegard LysneDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway. vegard.lysne@uib.no.
Elin StrandDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway. elin.strand@uib.no.
Gard F T SvingenDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway. gard.frodahl.tveitevag.svingen@helse-bergen.no.
Bodil BjørndalDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway. Bodil.Bjorndal@k2.uib.no.
Eva R PedersenDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway. eva.pedersen@k2.uib.no.
Øivind MidttunBevital AS, 5021 Bergen, Norway. Bjorn.Midttun@uib.no.
Thomas OlsenDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway. olsen.thomas89@gmail.com.
Per M UelandDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway. per.ueland@ikb.uib.no.
Rolf K BergeDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway. Rolf.Berge@uib.no.
Ottar NygårdDepartment of Clinical Science, University of Bergen, 5020 Bergen, Norway. Ottar.Nygard@helse-bergen.no.
Haukeland University Hospital · NOUniversity of Bergen · NOBevital (Norway) · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasma concentrations of metabolites along the choline oxidation pathway have been linked to increased risk of major lifestyle diseases, and peroxisome proliferator-activated receptors (PPARs) have been suggested to be involved in the regulation of key enzymes along this pathway. In this study, we investigated the effect of PPAR activation on circulating and urinary one-carbon metabolites as well as markers of B-vitamin status. Male Wistar rats (n = 20) received for 50 weeks either a high-fat control diet or a high-fat diet with tetradecylthioacetic acid (TTA), a modified fatty acid and pan-PPAR agonist with high affinity towards PPARα. Hepatic gene expression of PPARα, PPARβ/δ and the enzymes involved in the choline oxidation pathway were analyzed and concentrations of metabolites were analyzed in plasma and urine. TTA treatment altered most biomarkers, and the largest effect sizes were observed for plasma concentrations of dimethylglycine, nicotinamide, methylnicotinamide, methylmalonic acid and pyridoxal, which were all higher in the TTA group (all p < 0.01). Hepatic Pparα mRNA was increased after TTA treatment, but genes of the choline oxidation pathway were not affected. Long-term TTA treatment was associated with pronounced alterations on the plasma and urinary concentrations of metabolites related to one-carbon metabolism and B-vitamin status in rats.

Indexed as

AnimalsAntioxidantsCholineDiet, High-FatGene ExpressionLiverMaleMetabolic Networks and PathwaysMethylmalonic AcidNiacinamideNicotinic AcidsOne-Carbon Group TransferasesPeroxisome Proliferator-Activated ReceptorsPPAR alphaPPAR-betaPyridoxal1-(carboxymethylthio)tetradecaneAntioxidantsCholinedimethylglycineMethylmalonic Acidmethyl nicotinateNiacinamideNicotinic AcidsOne-Carbon Group TransferasesPeroxisome Proliferator-Activated ReceptorsPPAR alphaPPAR-betaPyridoxalRNA, MessengerSarcosineSulfidesVitamin B Complexdimethylglycinemethylmalonic acidone-carbon metabolismperoxisome proliferator-activated receptorstetradecylthioacetic acid

Identifiers

PMID26742069
PMCPMC4728640
OpenAlexW2222095932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.